PRECAST PI, Dr. Nikola Knežević, received EU grant funding for three years under the Horizon 2020 Twinning program. EU-funded NANOFACTS project will further contribute to the PRECAST project by improving research capabilities and collaboration in the field of cancer theranostics and biosensor-based cancer diagnostics between the BioSense Institute and leading European research institutions. This project will enable researchers from the BioSense institute to collaborate with researchers from Trinity College Dublin and enhance knowledge on devising theranostic nanoparticles for real-time in vivo detection of cancer biomarkers, along with simultaneous targeted cancer therapy and imaging. Furthermore, collaboration with Vienna University of Technology will enhance the capacity of biosensing technologies at the BioSense Institute with cancer-related biosensing.